Novel estrogen receptor-targeting agent represents ‘quantum leap’

Ductal carcinoma in situ: Anastrozole versus tamoxifen

Update on management of the axilla

Higher local recurrence after skin-sparing than simple mastectomy for DCIS

Peri-operative lapatinib has profound antiproliferative effect in early breast cancer

Guidelines and management of advanced breast cancer in limited resource settings

New developments and technologies in hereditary cancer

Results of the CREATE-X trial

Hormonal treatments produce similar quality of life outcomes in DCIS

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen

Treating women with endocrine-resistant HR /HER2 advanced breast cancer

No significant difference in recurrence rates among women with DCIS taking anastrozole or tamoxifen